170 related articles for article (PubMed ID: 11257651)
1. Fluorescence endoscopy with 5-aminolevulinic acid reduces early recurrence rate in superficial bladder cancer.
Riedl CR; Daniltchenko D; Koenig F; Simak R; Loening SA; Pflueger H
J Urol; 2001 Apr; 165(4):1121-3. PubMed ID: 11257651
[TBL] [Abstract][Full Text] [Related]
2. Long-term benefit of 5-aminolevulinic acid fluorescence assisted transurethral resection of superficial bladder cancer: 5-year results of a prospective randomized study.
Daniltchenko DI; Riedl CR; Sachs MD; Koenig F; Daha KL; Pflueger H; Loening SA; Schnorr D
J Urol; 2005 Dec; 174(6):2129-33, discussion 2133. PubMed ID: 16280742
[TBL] [Abstract][Full Text] [Related]
3. [The impact of ALA (5-aminolevulinic acid)-fluorescence detection on the prognosis of superficial bladder cancer].
Daniltchenko D; Riedl C; Koenig F; Daha LK; Sachs M; Schnorr D
Aktuelle Urol; 2004 Nov; 35(6):497-501. PubMed ID: 15526230
[TBL] [Abstract][Full Text] [Related]
4. Clinically relevant reduction in risk of recurrence of superficial bladder cancer using 5-aminolevulinic acid-induced fluorescence diagnosis: 8-year results of prospective randomized study.
Denzinger S; Burger M; Walter B; Knuechel R; Roessler W; Wieland WF; Filbeck T
Urology; 2007 Apr; 69(4):675-9. PubMed ID: 17445650
[TBL] [Abstract][Full Text] [Related]
5. Transurethral resection for bladder cancer using 5-aminolevulinic acid induced fluorescence endoscopy versus white light endoscopy.
Kriegmair M; Zaak D; Rothenberger KH; Rassweiler J; Jocham D; Eisenberger F; Tauber R; Stenzl A; Hofstetter A
J Urol; 2002 Aug; 168(2):475-8. PubMed ID: 12131291
[TBL] [Abstract][Full Text] [Related]
6. Clinically relevant improvement of recurrence-free survival with 5-aminolevulinic acid induced fluorescence diagnosis in patients with superficial bladder tumors.
Filbeck T; Pichlmeier U; Knuechel R; Wieland WF; Roessler W
J Urol; 2002 Jul; 168(1):67-71. PubMed ID: 12050494
[TBL] [Abstract][Full Text] [Related]
7. [Reducing the risk of superficial bladder cancer recurrence with 5-aminolevulinic acid-induced fluorescence diagnosis. Results of a 5-year study].
Filbeck T; Pichlmeier U; Knuechel R; Wieland WF; Rössler W
Urologe A; 2003 Oct; 42(10):1366-73. PubMed ID: 14569386
[TBL] [Abstract][Full Text] [Related]
8. 5-aminolevulinic acid-induced fluorescence endoscopy applied at secondary transurethral resection after conventional resection of primary superficial bladder tumors.
Filbeck T; Roessler W; Knuechel R; Straub M; Kiel HJ; Wieland WF
Urology; 1999 Jan; 53(1):77-81. PubMed ID: 9886592
[TBL] [Abstract][Full Text] [Related]
9. 5-aminolaevulinic acid-induced fluorescence cystoscopy during transurethral resection reduces the risk of recurrence in stage Ta/T1 bladder cancer.
Babjuk M; Soukup V; Petrík R; Jirsa M; Dvorácek J
BJU Int; 2005 Oct; 96(6):798-802. PubMed ID: 16153204
[TBL] [Abstract][Full Text] [Related]
10. [Clinical significance of macroscopic 5-aminolevulinic acid (ALA)-inducer fluorescence in transurethral resection of non-invasive bladder cancer].
Danil'chenko DI; Koenig F; Riedl K; Schnorr D; Waldman A; Al-Shukri S; Loening SA
Vopr Onkol; 2003; 49(6):734-7. PubMed ID: 14976918
[TBL] [Abstract][Full Text] [Related]
11. Oral 5-aminolevulinic acid in simultaneous photodynamic diagnosis of upper and lower urinary tract transitional cell carcinoma - a prospective audit.
Ahmad S; Aboumarzouk O; Somani B; Nabi G; Kata SG
BJU Int; 2012 Dec; 110(11 Pt B):E596-600. PubMed ID: 22758907
[TBL] [Abstract][Full Text] [Related]
12. [Clinical experience with intravesical instillations of 5-aminolevulinic acid (5-ALA) for the photodynamic diagnosis using fluorescence cystoscopy for bladder cancer].
Inoue K; Karashima T; Kamada M; Kurabayashi A; Ohtsuki Y; Shuin T
Nihon Hinyokika Gakkai Zasshi; 2006 Jul; 97(5):719-29. PubMed ID: 16898595
[TBL] [Abstract][Full Text] [Related]
13. Clinical results of the transurethreal resection and evaluation of superficial bladder carcinomas by means of fluorescence diagnosis after intravesical instillation of 5-aminolevulinic acid.
Filbeck T; Roessler W; Knuechel R; Straub M; Kiel HJ; Wieland WF
J Endourol; 1999 Mar; 13(2):117-21. PubMed ID: 10213106
[TBL] [Abstract][Full Text] [Related]
14. [Fluorescent endoscopy superior to white light endoscopy. Detecting cancers of the urinary bladder earlier].
Zaak D
MMW Fortschr Med; 2002 Mar; 144(13):24-6. PubMed ID: 12001582
[TBL] [Abstract][Full Text] [Related]
15. Hexaminolevulinate is equal to 5-aminolevulinic acid concerning residual tumor and recurrence rate following photodynamic diagnostic assisted transurethral resection of bladder tumors.
Burger M; Stief CG; Zaak D; Stenzl A; Wieland WF; Jocham D; Otto W; Denzinger S
Urology; 2009 Dec; 74(6):1282-6. PubMed ID: 19819538
[TBL] [Abstract][Full Text] [Related]
16. Hexaminolevulinate-induced fluorescence versus white light during transurethral resection of noninvasive bladder tumor: does it reduce recurrences?
Karaolides T; Skolarikos A; Bourdoumis A; Konandreas A; Mygdalis V; Thanos A; Deliveliotis C
Urology; 2012 Aug; 80(2):354-9. PubMed ID: 22857752
[TBL] [Abstract][Full Text] [Related]
17. [Fluorescence endoscopy in the diagnosis and treatment of superficial bladder neoplasms].
Zani D; Simeone C; Cosciani Cunico S; da Pozzo GP
Minerva Urol Nefrol; 2005 Dec; 57(4):335-9. PubMed ID: 16247356
[TBL] [Abstract][Full Text] [Related]
18. Prospective randomized trial of hexylaminolevulinate photodynamic-assisted transurethral resection of bladder tumour (TURBT) plus single-shot intravesical mitomycin C vs conventional white-light TURBT plus mitomycin C in newly presenting non-muscle-invasive bladder cancer.
O'Brien T; Ray E; Chatterton K; Khan MS; Chandra A; Thomas K
BJU Int; 2013 Dec; 112(8):1096-104. PubMed ID: 24053153
[TBL] [Abstract][Full Text] [Related]
19. 5-Aminolevulinic acid-induced fluorescence endoscopy for the detection of lower urinary tract tumors.
Kriegmair M; Zaak D; Knuechel R; Baumgartner R; Hofstetter A
Urol Int; 1999; 63(1):27-31. PubMed ID: 10592487
[TBL] [Abstract][Full Text] [Related]
20. [Role of fluorescent control in raising radicality of surgical treatment for superficial bladder cancer].
Matveev BP; Kudashev BV; Bukharkin BV; Romanov VA; Rubanov IuV
Urologiia; 2000; (3):22-4. PubMed ID: 11186703
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
